Abdominal Obesity Phenotypes and Incidence of Type 2 DM, Cardiovascular Outcomes and All‐Cause Mortality—A Systematic Review and Meta‐Analysis

Background and Aims: The global rise in obesity, a major driver of metabolic diseases, has prompted scrutiny of distinct obesity phenotypes. While overall obesity is concerning, abdominal obesity demonstrates a stronger association with metabolic dysfunction, type 2 diabetes (DM2), and cardiovascular disease (CVD). This review examines the risk of DM2, CVD, and mortality in adults with a metabolically healthy abdominal obese phenotype. Methods: ² statistic. Results: ² > 50%) was observed, partly explained by differences in outcome definitions and metabolic classifications. Conclusion: PROSPERO (CRD42019111056).